Artificial Intelligence (AI) In Drug Discovery
Nov 05, 2025
AI Hospitals of the Future–Where Robotics, Predictive Analytics, and Compassion Converge
The global healthcare landscape is undergoing one of the most transformative revolutions in modern history. At the heart of this evolution lies Artificial Intelligence (AI), a force that is not just augmenting medical workflows but reshaping how hospitals function, how care is delivered, and how humanity interacts ...
Read More...
Oct 22, 2025
The AI Drug Discovery Revolution: Smarter Science, Faster Therapies, Better Outcomes
The pharmaceutical industry has always been a high-stakes arena, where years of research, billions of dollars, and countless clinical trials culminate in a single therapy reaching patients. Despite tremendous advancements, the traditional drug discovery process remains time-consuming, costly, and fraught with uncer...
Read More...
Jun 11, 2025
AI Healthcare Startups: Unveiling Investment and Funding Trends
Buckle up, because the world of AI healthcare startups is on fire! Investors are throwing serious cash, think billions, at companies using artificial intelligence to shake up the pharmaceutical industry. Over the past decade, a jaw-dropping USD 60 billion has flooded into AI healthcare startups, with USD 30 billion...
Read More...
May 14, 2025
Generative AI in Drug Discovery: Applications and Market Impact
The pharmaceutical industry stands at a crossroads, where innovation is no longer a luxury but a necessity. The AI in the drug discovery market is at the forefront of this transformation, driven by the remarkable capabilities of generative AI. This technology, which creates novel solutions by learning from vast dat...
Read More...
Apr 09, 2025
AI-Driven Diagnostics: Why are They the Next Big Thing in Healthcare?
Just a few years back, imagining a machine detecting a heart attack before symptoms surfaced or spotting a tumor more accurately than the human eye sounded like science fiction. Today, it’s just another day in AI-powered healthcare diagnostics. Artificial Intelligence is no longer a distant promise; it's a livin...
Read More...
Dec 26, 2024
FDA Grants Approval to Merit Medical’s WRAPSODY Endoprosthesis; FDA Clears AVITA Medical’s Cohealyx, Expanding Treatment Potential; SeaStar Medical Launches 14th Location for Adult AKI Pivotal Study; Contego Medical’s Neuroguard IEP System Treats First Patients; SMT Introduces Hydra™ TAVI System in Russia; SandboxAQ Raises $300M+ to Accelerate AI’s Next Frontier
Merit Medical Announced FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis On December 20, 2024, Merit Medical Systems, Inc., a leading global manufacturer and marketer of advanced healthcare technologies, announced that its WRAPSODY® Cell-Impermeable Endoprosthesis received premarket approval (P...
Read More...
Aug 01, 2024
Stryker’s Spine Guidance 5 Software FDA Approval; VIALASE Received CE Mark; The Texas Heart Institute Implanted the BiVACOR® Total Artificial Heart; Diamyd Medical’s Phase 3 Trial Positive Results; Cardio Diagnostics Holdings Inc.’s CDIO.AI; GE Healthcare and AWS Strategic Collaboration
FDA Approved Stryker’s Spine Guidance 5 Software Featuring Copilot On July 30, 2024, Stryker, a global leader in medical technologies, announced that its Q Guidance System with Spine Guidance 5 Software featuring Copilot received 510(k) clearance from the U.S. Food and Drug Administration. This first-to-market t...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
